Cargando…

Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management

A potential risk associated with vaccines for COVID-19 is antibody-dependent disease enhancement (ADE) in which vaccine induced antibody mediated immune responses may lead to enhanced SARS CoV- 2 acquisition or increased disease severity. Though ADE has not been clinically demonstrated with any of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikewaki, Nobunao, Kurosawa, Gene, Levy, Gary A., Preethy, Senthilkumar, Abraham, Samuel J.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992059/
https://www.ncbi.nlm.nih.gov/pubmed/36906407
http://dx.doi.org/10.1016/j.vaccine.2023.03.005